Levent YENİAY et al. 2019. Prognostic value of somatostatin receptor-2 positivity in gastroenteropancreatic neuroendocrine tumors in reference to known prognostic factors. Turkish Journal of Gastroenterology. 23, 6 (Jul. 2019), 736–740.